Body weight and fat mass across the menopausal transition: hormonal modulators

References

• Jones GL, Sutton A. Quality of life in obese postmenopausal women. Menopause Int. 2008;14:3847–3853.
   Google Scholar
• Manrique-Acevedo C, Chinnakotla B, Padilla J, et al. Obesity and cardiovascular disease in women. Int J Obes (Lond). 2020;44(6):1210–1226.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. OECD.org. [accessed 10 October 2021]. Available from: https://www.oecd.org/health/health-systems/Obesity-Update-2017.pdf
   Google Scholar
• Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-Level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–2450.
   PubMed Web of Science ®Google Scholar
• Kapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin Proc. 2017;92(10):1552–1558.
   PubMed Web of Science ®Google Scholar
• Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177–189.
   PubMed Web of Science ®Google Scholar
• Grainger AT, Krishnaraj A, Quinones MH, et al. Deep learning-based quantification of abdominal subcutaneous and visceral fat volume on CT images. Acad Radiol. 2020; S1076–6332:30426–30428.
   Google Scholar
• Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399–409.
   PubMed Web of Science ®Google Scholar
• Raz I, Eldor R, Cernea S, et al. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev. 2005;21(1):3–14.
   PubMed Web of Science ®Google Scholar
• Smith U, Kahn BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med. 2016;280(5):465–475.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Circulation. 2008;117(13):1658–1667.
   PubMed Web of Science ®Google Scholar
• Jensen MD. Visceral fat: culprit or canary? Endocrinol Metab Clin North Am. 2020;49(2):229–237.
   PubMed Web of Science ®Google Scholar
• Medina-Contreras J, Villalobos-Molina R, Zarain-Herzberg A, et al. Ovariectomized rodents as a menopausal metabolic syndrome model. A minireview. Mol Cell Biochem. 2020;475(1–2):261–276.
   PubMed Web of Science ®Google Scholar
• Sornay-Rendu E, Karras-Guillibert C, Munoz F, et al. Age determines longitudinal changes in body composition better than menopausal and bone status: the OFELY study. J Bone Miner Res. 2012;27(3):628–636.
   PubMed Web of Science ®Google Scholar
• Lovejoy JC, Champagne CM, de Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949–958.
   Web of Science ®Google Scholar
• Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865.
   PubMed Web of Science ®Google Scholar
• Ambikairajah A, Walsh E, Tabatabaei-Jafari H, et al. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol. 2019;221(5):393–409.
   PubMed Web of Science ®Google Scholar
• Imboden MT, Welch WA, Swartz AM, et al. Reference standards for body fat measures using GE dual energy x-ray absorptiometry in Caucasian adults. PLoS One. 2017;12(4):e0175110.
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome; the study of women’s health across the nation. Arch Intern Med. 2008;168(14):1568–1575.
   PubMedGoogle Scholar
• Khan UI, Wang D, Karvonen-Gutierrez CA, et al. Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN). J Clin Endocrinol Metab. 2014;99(7):2516–2525.
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847–3853.
   PubMed Web of Science ®Google Scholar
• Kostakis EK, Gkioni LN, Macut D, et al. Androgens in menopausal women: not only polycystic ovary syndrome. Front Horm Res. 2019; 53:135–161.
   PubMed Web of Science ®Google Scholar
• Ofori EK, Conde Alonso S, Correas-Gomez L, et al. Thigh and abdominal adipose tissue depot associations with testosterone levels in postmenopausal females. Clin Endocrinol. 2019;90(3):433–439.
   PubMed Web of Science ®Google Scholar
• Ruth KS, Day FR, Tyrrell J, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252–258.
   PubMed Web of Science ®Google Scholar
• Simons PIHG, Valkenburg O, Bons JAP, et al. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome. Endocrinol Diabetes Metab. 2021;4(3):e00267.
   PubMedGoogle Scholar
• van Pelt RE, Gavin KM, Kohrt WM. Regulation of body composition and bioenergetics by estrogens. Endocrinol Metab Clin North Am. 2015;44(3):663–676.
   PubMed Web of Science ®Google Scholar
• Melanson EL, Gavin KM, Shea KL, et al. Regulation of energy expenditure by estradiol in premenopausal women. J Appl Physiol. 2015;119(9):975–981.
   PubMed Web of Science ®Google Scholar
• Shea KL, Gavin KM, Melanson EL, et al. Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause. 2015;22(10):1045–1052.
   PubMed Web of Science ®Google Scholar
• Vujović S, Ivovic M, Tančić-Gajić M, et al. Effects of different menopause hormone therapy routes of administration on insulin levels in early menopausal non-diabetic subjects. Gynecol Reprod Endocrinol Metab. 2021;2:60–64.
   Google Scholar
• Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal estrogen-progestin interventions study investigators. J Clin Endocrinol Metab. 1997;82(5):1549–1556.
   PubMedGoogle Scholar
• Utian WH, Gass MLS, Pickar JH. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. Menopause. 2004;11(3):306–314.
   PubMed Web of Science ®Google Scholar
• Chen Z, Bassford T, Green SB, et al. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the women’s health initiative. Am J Clin Nutr. 2005;82(3):651–656.
   PubMed Web of Science ®Google Scholar
• Jensen LB, Vestergaard P, Hermann AP, et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish osteoporosis prevention study. J Bone Miner Res. 2003;18(2):333–342.
   PubMed Web of Science ®Google Scholar
• Casarini L, Crépieux P. Molecular mechanisms of action of FSH. Front Endocrinol (Lausanne). 2019;10:305.
   PubMed Web of Science ®Google Scholar
• Taneja C, Gera S, Kim SM, et al. FSH-metabolic circuitry and menopause. J Mol Endocrinol. 2019;63(3):R73–R80.
   PubMed Web of Science ®Google Scholar
• Zaidi M, New MI, Blair HC, et al. Actions of pituitary hormones beyond traditional targets. J Endocrinol. 2018;237(3):R83–R98.
   PubMed Web of Science ®Google Scholar
• Liu P, Ji Y, Yuen T, et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017;546(7656):107–112.
   PubMed Web of Science ®Google Scholar
• Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125(2):247–260.
   PubMed Web of Science ®Google Scholar
• Liu X, Chan HC, Ding G, et al. FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca(2+)/CREB pathway. Aging Cell. 2015;14(3):409–420.
   PubMed Web of Science ®Google Scholar
• Gera S, Sant D, Haider S, et al. First-in-class humanized FSH blocking antibody targets bone and fat. Proc Natl Acad Sci USA. 2020;117(46):28971–28979.
   PubMed Web of Science ®Google Scholar
• Veldhuis-Vlug AG, Woods GN, Sigurdsson S, et al. Serum FSH is associated with bmd, bone marrow adiposity, and body composition in the AGES-Reykjavik study of older adults. J Clin Endocrinol Metab. 2021;106(3):e1156-69–e1169.
   Web of Science ®Google Scholar
• Finkelstein JS, Lee H, Burnett-Bowie SAM, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011–1022.
   PubMed Web of Science ®Google Scholar
• Østergren PB, Kistorp C, Fode M, et al. Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study. BJU Int. 2019;123(4):602–611.
   PubMed Web of Science ®Google Scholar
• Lin YM, Velmurugan BK, Yeh YL, et al. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Oncol Rep. 2013;30(6):3027–3031.
   PubMed Web of Science ®Google Scholar
• Aribas E, Kavousi M, Laven JSE, et al. Aging, cardiovascular risk, and SHBG levels in men and women from the general population. J Clin Endocrinol Metab. 2021;106(10):2890–2900.
   PubMed Web of Science ®Google Scholar
• Simons PIHG, Valkenburg O, Stehouwer CDA, et al. Sex hormone-binding globulin: biomarker and hepatokine? Trends Endocrinol Metab. 2021;32(8):544–553.
   PubMed Web of Science ®Google Scholar